Is KNTE or SPHD a better dividend investment in 2026?

KNTE currently yields 75.47% with a 5% 5-year dividend growth rate. SPHD yields 4.00% with 5% growth. The better choice depends on your goal: KNTE offers higher current income.

What is the dividend yield difference between KNTE and SPHD?

KNTE has a forward dividend yield of 75.47% ($2.00/share annually). SPHD yields 4.00% ($2.00/share annually). The yield gap is 71.47 percentage points.

Home › Compare › KNTE vs SPHD

KNTE vs SPHD: Dividend Comparison 2026

KNTE yields 75.47% · SPHD yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KNTE wins by $1.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KNTE

● Live price

75.47%

Share price

$2.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.35M

Annual income

$375,142.22

Full KNTE calculator →

SPHD

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full SPHD calculator →

Portfolio growth — KNTE vs SPHD

📍 KNTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KNTE	SPHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KNTE + SPHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KNTE pays

SPHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KNTE

Annual income on $10K today (after 15% tax)

$6,415.09/yr

After 10yr DRIP, annual income (after tax)

$318,870.89/yr

SPHD

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, KNTE beats the other by $318,106.58/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KNTE + SPHD for your $10,000?

KNTE: 50%SPHD: 50%

100% SPHD50/50100% KNTE

Portfolio after 10yr

$690.5K

Annual income

$188,020.71/yr

Blended yield

27.23%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on KNTE right now

KNTE

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$30.00

+1032.1% upside vs current

Range: $30.00 — $30.00

Altman Z

1.0

Piotroski

2/9

SPHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KNTE buys

SPHD buys

No recent congressional trades found for KNTE or SPHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKNTESPHD

Forward yield	75.47% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$1.35M	$28.0K ✓
Annual income after 10y	$375,142.22 ✓	$899.19
Total dividends collected	$1.17M	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: KNTE vs SPHD ($10,000, DRIP)

Year	KNTE Portfolio	KNTE Income/yr	SPHD Portfolio	SPHD Income/yr	Gap
1← crossover	$18,247	$7,547.17	$11,120	$420.00	+$7.1K → KNTE
2	$32,395	$12,870.51	$12,357	$458.31	+$20.0K → KNTE
3	$56,017	$21,354.74	$13,721	$499.76	+$42.3K → KNTE
4	$94,449	$34,510.84	$15,227	$544.58	+$79.2K → KNTE
5	$155,442	$54,381.15	$16,885	$593.02	+$138.6K → KNTE
6	$249,967	$83,643.80	$18,713	$645.34	+$231.3K → KNTE
7	$393,173	$125,708.24	$20,724	$701.81	+$372.4K → KNTE
8	$605,486	$184,791.09	$22,938	$762.73	+$582.5K → KNTE
9	$913,831	$265,960.98	$25,372	$828.41	+$888.5K → KNTE
10	$1,352,941	$375,142.22	$28,047	$899.19	+$1.32M → KNTE

KNTE vs SPHD: Complete Analysis 2026

KNTE — Stock

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.

Full KNTE Calculator →

SPHD — ETF

SPHD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPHD shares.

Full SPHD Calculator →

📬

Get this KNTE vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KNTE vs SCHD KNTE vs JEPI KNTE vs O KNTE vs KO KNTE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.